Nifty
Sensex
:
:
18726.40
63142.96
127.40 (0.69%)
350.08 (0.56%)

Pharmaceuticals & Drugs

Rating :
47/99

BSE: 532305 | NSE: INDSWFTLAB

71.00
07-Jun-2023
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  • 72.10
  • 72.60
  • 70.90
  • 71.90
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  55946
  •  40.08
  •  80.00
  •  52.65

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 424.42
  • 8.92
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,355.45
  • N/A
  • 0.85

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 42.00%
  • 7.12%
  • 29.08%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 21.80%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -0.89
  • 6.38
  • 10.04

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 10.59
  • 7.85
  • 6.40

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -33.00
  • -
  • -53.36

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 7.44
  • 11.99

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 0.79
  • 0.83
  • 0.90

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 9.46
  • 7.23
  • 6.48

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Var%
Dec 22
Dec 21
Var%
Sep 22
Sep 21
Var%
Jun 22
Jun 21
Var%
Net Sales
304.25
306.65
-0.78%
312.69
246.64
26.78%
310.21
235.64
31.65%
280.17
249.80
12.16%
Expenses
239.53
269.95
-11.27%
258.92
194.25
33.29%
251.46
179.59
40.02%
227.16
198.97
14.17%
EBITDA
64.71
36.69
76.37%
53.76
52.39
2.62%
58.75
56.06
4.80%
53.00
50.83
4.27%
EBIDTM
21.27%
11.97%
17.19%
21.24%
18.94%
23.79%
18.92%
20.35%
Other Income
10.21
21.21
-51.86%
8.36
8.41
-0.59%
7.54
7.15
5.45%
7.39
6.37
16.01%
Interest
21.82
23.49
-7.11%
22.38
23.73
-5.69%
23.98
24.19
-0.87%
23.98
24.12
-0.58%
Depreciation
9.29
81.81
-88.64%
15.39
21.26
-27.61%
16.41
13.91
17.97%
16.28
14.06
15.79%
PBT
17.16
-47.40
-
24.35
15.81
54.02%
25.91
25.10
3.23%
20.14
19.02
5.89%
Tax
41.17
14.06
192.82%
-3.27
-0.22
-
0.56
0.63
-11.11%
0.22
0.21
4.76%
PAT
-24.01
-61.45
-
27.62
16.03
72.30%
25.34
24.47
3.56%
19.92
18.80
5.96%
PATM
-7.89%
-20.04%
8.83%
6.50%
8.17%
10.38%
7.11%
7.53%
EPS
-4.08
-10.40
-
4.65
2.71
71.59%
4.29
4.14
3.62%
3.36
3.18
5.66%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Net Sales
1,207.32
1,038.73
891.34
779.64
756.60
762.52
697.42
653.25
660.45
965.08
1,136.09
Net Sales Growth
16.23%
16.54%
14.33%
3.05%
-0.78%
9.33%
6.76%
-1.09%
-31.57%
-15.05%
 
Cost Of Goods Sold
654.56
526.58
451.44
396.66
403.36
390.56
392.19
353.01
407.39
754.92
911.94
Gross Profit
552.76
512.15
439.90
382.98
353.24
371.96
305.24
300.23
253.07
210.16
224.15
GP Margin
45.78%
49.31%
49.35%
49.12%
46.69%
48.78%
43.77%
45.96%
38.32%
21.78%
19.73%
Total Expenditure
977.07
843.11
708.54
636.16
630.48
628.43
591.47
545.97
571.69
906.18
1,064.59
Power & Fuel Cost
-
57.54
37.31
34.65
37.44
29.58
26.00
22.65
34.78
36.82
31.61
% Of Sales
-
5.54%
4.19%
4.44%
4.95%
3.88%
3.73%
3.47%
5.27%
3.82%
2.78%
Employee Cost
-
104.66
97.86
95.92
90.98
88.12
69.65
62.76
50.65
44.95
40.57
% Of Sales
-
10.08%
10.98%
12.30%
12.02%
11.56%
9.99%
9.61%
7.67%
4.66%
3.57%
Manufacturing Exp.
-
63.58
64.24
59.30
50.06
63.50
43.40
38.56
30.13
26.35
29.14
% Of Sales
-
6.12%
7.21%
7.61%
6.62%
8.33%
6.22%
5.90%
4.56%
2.73%
2.56%
General & Admin Exp.
-
36.22
27.17
27.58
27.27
28.69
23.33
21.54
20.33
22.37
21.05
% Of Sales
-
3.49%
3.05%
3.54%
3.60%
3.76%
3.35%
3.30%
3.08%
2.32%
1.85%
Selling & Distn. Exp.
-
38.86
28.74
21.65
21.30
27.92
29.06
28.87
28.33
13.95
24.12
% Of Sales
-
3.74%
3.22%
2.78%
2.82%
3.66%
4.17%
4.42%
4.29%
1.45%
2.12%
Miscellaneous Exp.
-
15.67
1.77
0.40
0.07
0.06
7.86
18.57
0.09
6.82
24.12
% Of Sales
-
1.51%
0.20%
0.05%
0.01%
0.01%
1.13%
2.84%
0.01%
0.71%
0.54%
EBITDA
230.22
195.62
182.80
143.48
126.12
134.09
105.95
107.28
88.76
58.90
71.50
EBITDA Margin
19.07%
18.83%
20.51%
18.40%
16.67%
17.59%
15.19%
16.42%
13.44%
6.10%
6.29%
Other Income
33.50
43.48
22.71
33.46
36.91
25.82
22.62
15.91
22.25
14.17
17.87
Interest
92.16
95.53
100.22
106.65
92.24
35.38
90.27
106.42
117.29
116.66
139.72
Depreciation
57.37
131.04
87.29
90.06
104.05
86.62
88.26
84.75
84.29
65.77
54.35
PBT
87.56
12.53
18.01
-19.77
-33.26
37.92
-49.96
-67.98
-90.56
-109.35
-104.71
Tax
38.68
14.68
21.16
1.42
20.73
14.01
-16.17
-24.09
-23.98
-20.05
-0.94
Tax Rate
44.18%
117.16%
117.49%
-7.18%
41.73%
38.94%
29.24%
29.10%
16.73%
14.11%
0.79%
PAT
48.87
-2.15
-3.15
-21.19
28.95
21.98
-39.13
-58.69
-119.37
-122.01
-117.90
PAT before Minority Interest
48.87
-2.15
-3.15
-21.19
28.95
21.98
-39.13
-58.69
-119.37
-122.01
-117.90
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
4.05%
-0.21%
-0.35%
-2.72%
3.83%
2.88%
-5.61%
-8.98%
-18.07%
-12.64%
-10.38%
PAT Growth
2,373.02%
-
-
-
31.71%
-
-
-
-
-
 
EPS
8.27
-0.36
-0.53
-3.59
4.90
3.72
-6.62
-9.93
-20.20
-20.64
-19.95

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Shareholder's Funds
600.97
603.51
640.64
587.81
553.24
531.32
517.43
594.85
725.23
853.44
Share Capital
59.81
59.81
59.81
48.29
46.00
45.46
41.68
41.68
40.96
39.27
Total Reserves
541.17
543.70
580.83
539.53
505.69
483.39
475.74
553.17
674.95
804.85
Non-Current Liabilities
813.57
840.15
828.33
901.32
437.80
494.76
717.24
811.33
983.36
859.34
Secured Loans
847.78
884.13
885.96
953.86
503.97
563.69
666.84
723.03
862.23
756.52
Unsecured Loans
0.00
0.00
4.93
11.72
16.52
28.32
79.48
93.11
102.17
63.40
Long Term Provisions
17.03
15.73
14.76
14.34
13.32
9.16
0.00
0.00
0.00
0.00
Current Liabilities
334.50
314.52
323.07
356.00
935.93
1,005.02
950.81
832.82
630.01
663.04
Trade Payables
175.95
138.82
135.23
126.68
128.64
102.36
132.43
134.11
213.71
203.42
Other Current Liabilities
79.13
81.29
72.92
136.49
490.25
496.93
314.60
248.67
21.50
24.98
Short Term Borrowings
74.03
93.43
114.93
92.52
311.31
405.70
503.66
450.05
390.97
421.97
Short Term Provisions
5.39
0.98
0.00
0.31
5.73
0.03
0.12
0.00
3.83
12.67
Total Liabilities
1,748.93
1,758.09
1,792.04
1,845.13
1,926.97
2,031.10
2,185.48
2,239.00
2,338.60
2,375.82
Net Block
627.56
738.65
843.14
901.20
924.59
1,032.56
1,098.73
1,116.82
1,173.77
1,170.63
Gross Block
1,318.99
1,302.04
1,359.32
1,378.95
1,349.27
1,406.84
1,420.51
1,404.21
1,405.28
1,351.32
Accumulated Depreciation
691.42
563.38
516.18
477.75
424.68
374.28
321.78
287.40
231.51
180.68
Non Current Assets
672.55
813.91
929.00
1,009.05
1,087.71
1,202.46
1,263.78
1,319.18
1,349.72
1,350.77
Capital Work in Progress
10.31
18.84
11.45
19.87
68.60
70.26
78.47
112.83
78.10
161.30
Non Current Investment
29.06
35.53
17.45
31.03
31.02
31.09
17.63
17.52
17.07
17.04
Long Term Loans & Adv.
2.91
6.11
56.95
56.95
63.50
54.24
68.96
72.00
80.78
1.80
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
14.31
0.00
0.00
0.00
0.00
Current Assets
1,074.37
941.88
863.03
836.09
839.26
828.64
921.70
919.82
988.89
1,025.06
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.10
Inventories
428.50
375.67
342.82
316.61
316.91
343.56
356.02
348.31
377.03
451.44
Sundry Debtors
454.78
432.39
396.45
350.85
407.76
357.27
372.45
389.04
443.85
412.71
Cash & Bank
21.48
11.60
10.58
29.97
9.45
16.13
22.58
19.84
20.59
18.28
Other Current Assets
169.61
56.33
38.73
41.82
105.14
111.69
170.66
162.64
147.41
142.52
Short Term Loans & Adv.
113.45
65.90
74.45
96.84
92.09
95.37
157.41
144.03
126.33
115.33
Net Current Assets
739.87
627.36
539.96
480.08
-96.67
-176.37
-29.11
87.01
358.87
362.01
Total Assets
1,746.92
1,755.79
1,792.03
1,845.14
1,926.97
2,031.10
2,185.48
2,239.00
2,338.61
2,375.83

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Cash From Operating Activity
150.27
134.95
125.24
-64.40
73.09
95.57
79.43
98.40
65.53
-46.60
PBT
12.53
18.01
-19.77
-33.26
37.87
-49.96
-67.98
-90.57
-109.35
-104.78
Adjustment
225.66
179.35
176.02
186.26
103.64
167.95
186.30
169.93
144.59
111.52
Changes in Working Capital
-87.92
-62.41
-31.01
-214.80
-68.41
-22.42
-38.89
22.87
39.54
-53.34
Cash after chg. in Working capital
150.27
134.95
125.24
-61.80
73.09
95.57
79.43
102.23
74.78
-46.60
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
0.00
0.00
0.00
-2.60
0.00
0.00
0.00
-3.83
-9.25
0.00
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
4.77
-10.17
-9.10
-12.47
-17.40
-30.94
-29.56
-35.61
-27.39
-48.36
Net Fixed Assets
-8.59
50.42
31.26
19.05
59.23
21.87
18.07
-34.69
29.24
-176.19
Net Investments
-55.35
-28.97
12.52
0.24
0.23
-12.97
-0.05
0.88
0.06
2.06
Others
68.71
-31.62
-52.88
-31.76
-76.86
-39.84
-47.58
-1.80
-56.69
125.77
Cash from Financing Activity
-140.88
-123.75
-133.26
99.62
-61.98
-68.90
-47.92
-63.72
-37.76
66.31
Net Cash Inflow / Outflow
14.17
1.03
-17.12
22.76
-6.30
-4.27
1.94
-0.94
0.38
-28.65
Opening Cash & Equivalents
11.60
10.58
29.97
9.45
16.13
22.58
19.84
20.59
18.28
46.92
Closing Cash & Equivalent
25.77
11.61
10.58
29.97
9.45
16.13
21.78
19.84
20.59
17.82

Financial Ratios

Consolidated /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Book Value (Rs.)
68.33
66.35
70.21
73.01
65.58
58.08
56.78
67.21
93.07
125.78
ROA
-0.12%
-0.18%
-1.17%
1.53%
1.11%
-1.86%
-2.65%
-5.22%
-5.18%
-5.13%
ROE
-0.54%
-0.78%
-5.56%
8.99%
7.89%
-15.89%
-23.11%
-36.36%
-27.88%
-21.56%
ROCE
7.85%
8.31%
5.97%
9.25%
4.59%
2.19%
1.40%
-1.52%
-1.46%
1.24%
Fixed Asset Turnover
0.80
0.67
0.57
0.56
0.56
0.51
0.48
0.48
0.71
0.96
Receivable days
154.46
168.41
174.12
182.19
181.25
185.94
206.44
223.20
158.98
113.33
Inventory Days
140.01
145.99
153.65
152.15
156.48
178.26
190.95
194.38
153.77
149.59
Payable days
109.09
110.78
68.85
63.73
60.79
64.19
12.73
29.95
80.99
75.54
Cash Conversion Cycle
185.38
203.62
258.91
270.60
276.94
300.00
384.67
387.63
231.76
187.37
Total Debt/Equity
2.35
2.56
2.48
3.21
4.38
4.77
6.25
5.12
3.56
2.51
Interest Cover
1.13
1.18
0.81
1.54
2.02
0.39
0.22
-0.22
-0.22
0.15

News Update:


  • Ind-Swift Laboratories gets nod to sell M/s. Halcyon life Sciences
    31st Mar 2023, 10:29 AM

    The Audit Committee and Board of the Directors of the Company at its meeting held on March 30, 2023 has approved the same

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.